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Abstract 
Over the last two decades, HIV has been the greatest public health challenge confronting the world. The threat 
that HIV/AIDS has posed to the health of citizens across the world has been severe making it the most 
devastating pandemic and this has led nations to declare it a national disaster. Sub –Sahara Africa has been the 
most affected region. There are approximately 6,000 new HIV infections occurring on daily basis mostly in 
developing countries with young people in the age bracket (15- 24) years representing more than 33% of the 
total new HIV infections.  In 1990, the global HIV incidence rate was 0.03 percent and in 2015, the rate stood at 
0.04 percent. On the other hand, there has been a rising trend in HIV/AIDS expenditure. For the period 2000 to 
2015, $562.6 billion was directed towards HIV fight globally. While the response to AIDS menace has been 
incredible demonstrating global unity and transformative collective responsibility, deep concern has been 
expressed on the number of new infections as 90% of the newly infected persons lived in 35 countries. Majority 
of these countries are in the sub-Saharan Africa. This study used a longitudinal research design whereby data 
from 11 sub-Saharan countries on HIV/AIDS expenditure and HIV/AIDS incidence rates over a number of 
years were analyzed. The study conformed to a number of studies that have shown that there exists a 
relationship between HIV/AIDS expenditure and HIV/AIDS incidence rate. Therefore, to reduce new HIV 
infections, there is need to allocate more resources.  
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1. Introduction 
Over time, HIV epidemic has remained a dominant health and human right challenge that has posed serious 
challenges to the development of human resource in families, communities and nations across the world. Since 
the beginning of the epidemic there have been an estimated 77 million HIV infections and that 35 million people 
have lost their lives courtesy of from AIDS [1]. Globally, HIV/AIDS has been identified as the leading cause of 
loss of human life among adolescent girls and generally women of reproductive age. According to [1] there are 
6,000 new infections occurring every day, mostly in developing countries and among the 36.9 million living 
with HIV, more than half of this population are not conscious of their HIV status.  Africa has been on the 
receiving end in terms of the pain endured from HIV with the Sub-Saharan Africa region carrying an enormous 
disproportionate burden. As of 2013, two out every three newly infected persons lived in Sub-Saharan Africa 
implying that Sub-Saharan region accounted for over 70% of the world new HIV infections. Women in Sub-
Sahara Africa are the most affected compared to their male counter parts as young women of age 15 years to 24 
years and adolescent girls are eight times more likely to get infected[2].  Countries all over the world have 
developed frameworks to improve health outcomes of their citizens among other social concerns [3]. HIV/AIDS 
being one of the greatest health concerns, more spending has been committed to current measures of HIV 
prevention and care. Such spending is to subsidize the delivery of AIDS education and health –care service 
which is intended to benefit in a profound way the population at large improving health status, reducing 
morbidity, raising literacy and numeracy, expanding opportunities for economic and social well-being.   The 
distinguished global efforts in ensuring the AIDs epidemic is eradicated as stipulated in the 2030 Agenda for 
Sustainable Development Goals remains to be the incomparable commitment to ensuring modern- day health 
issues related to HIV/AIDS are well addressed. The framework of the strategy on global health sector with the 
focus on HIV, for the period 2016-2021 is anchored on the premise of ensuring zero new HIV infections, zero 
discrimination with regard to HIV and in general zero HIV-related deaths where HIV positive persons have 
equal opportunities in the society. [4] As a key element in the 2030 Agenda for the Sustainable Development, 
health sector has been identified play a key role. The international community has committed to eradicate the 
AIDS catastrophe and the entire health sector is expected to play a key role in achieving these targets.  
1.1 HIV/AIDS burden 
Despite the increasing collective measures to fight HIV, the HIV epidemic continues to be a global scare where 
new infections continue to be reported as well as alarming HIV related mortality [5]. In 2015, 2.1 Million people 
were reported to have been infected, 36.69 million persons were living with while 1.1 million people succumbed 
to HIV[1].  According to [2], the number of HIV positive persons was 35 million globally in the year 2013. Sub-
Saharan Africa region accounted for 71 per cent of worldwide burden of the total HIV infection despite being 
home to 12% of the entire world population. There is still uneven distribution of the burden in Sub-Saharan as 
ten countries within sub-Saharan Africa in  Eastern and Southern Africa being South Africa (25%), Uganda 
(6%), Kenya (6%), Tanzania (6%), Nigeria ( 13%), Malawi (4%), Mozambique (6%), Zambia (4 %), Zimbabwe 
(6%) and lastly Ethiopia (3%) accounted for approximately 80 per cent of all persons who were living with 
HIV[2]. There has been a declining trend of new HIV infection over the several years of interventionist 
measures across sub-Saharan countries. The number of new infections was 1.51 million in 2013 as compared to 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2019) Volume 48, No  5, pp 1-9 
 
3 
 
2.1 million persons that got infected in 2005. Even though the statistics are still high, there was a significant 
reduction of more than 33 percent in the new HIV infections. Despite the reduction, it is worth noting that more 
than 75 percent of the world 2.1 million new HIV infections occurred within fifteen countries [2]. The new 
infections occurred disproportionately within sub-Saharan Africa. Figure 1 shows how different countries within 
sub-Saharan Africa shared the burden of new HIV infections.  
 
Figure 1: Global share of new HIV infection 
Source: [2] 
There have been significant worldwide gains made worldwide in bringing down new HIV infections cases over 
the last two decades. While the results on the trend of new infections are appreciated, the progress is deemed 
inadequate. There have been mixed results in the sense that while some regions have been registering substantial 
reductions in the newly infected persons, there are others that have been witnessing rising numbers in terms of 
new infections. The number of newly infected population fell by approximately 8% from 2010 to 2014 [5]. With 
the emergence of new prevention approaches and new prevention tools, prevention programs have been 
dwindling in recent years courtesy of declining HIV programs funding, poor accountability and partly 
inadequate leadership. 
1.2 Global trend of new HIV infections 
In the year 2016, the global incidence rate was 0.05%. This was half of the global incidence rate of 0.1% that 
was reported in 1990 [6]. Global statistics indicate a varying pattern of the new HIV infection patterns around 
the world. Countries in Latin America and in Asia have enjoyed incidence rates of lower that 0.1% while some 
African countries suffer higher incidence rates such South Africa where 1.44% of the total population got new 
infected in 2015 [6]. Figure 2 shows the global trend of new infections from 1990 to 2016. 
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Figure 2: Global trend of new HIV infection 
Source: World Bank WDI  
Global new HIV infections have reduced tremendously by 54% compared to the highest ever recorded new 
infection statistics in 2000. In 2016, the number of new HIV infections was 1.87 compared to 3.13 million that 
was reported in 2000. In a period of six years, from 2010 to 2016, global new HIV infections declined by 18%. 
There is however renewed concerns that the annual statistics of new HIV infections among adults has been static 
in recent years. 
1.3 Sub-Saharan Africa trend of new infections  
Global statistics suggest that sub-Saharan Africa continues to report high prevalence rates compared to global 
figures. Figure 3 shows the results of selected world regions and the outcome is not impressive for sub-Saharan 
region.  
 
Figure 3: Sub-Saharan Africa new HIV infection trend 
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Source: World Bank WDI  
The sub-Saharan Africa region continues to suffer disproportionately when it comes to the global share of HIV 
burden. From figure 3, HIV incidence rate exhibits an increasing trend from 1990 up to 1996 where the rate of 
new infection begins to decrease. The incidence rate in 2015 was 0.3 percent. Some countries have reported a 
declining tendency of new infections while others have recorded rising statistics of new infections.      
1.4 HIV/AIDS expenditure 
In the last three decades, there has been great advancement in the collective global HIV response. This has been 
coupled with unprecedented health innovations and increased financial investment. However, despite all these 
developments, there exist serious service gaps in the response mechanisms. Over the last two decades, huge 
resources have been mobilized as part of the response to address HIV/AIDs. In the fight against HIV and its 
effects, there has been unending gap between the necessary resources required to support several programs and 
the actual amount allocated for HIV programs. In 2011, there was a global call by the United Nations` Political 
Declaration centred on HIV and AIDS to aid the process of mobilizing funding as part of the global HIV 
response. The international community was called upon to marshal between 22 billion US Dollars and 24 billion 
US Dollars which would stretch up to 2015. This was however not actualized by the end of 2016 as the actual 
funding channelled to the low-income and middle-income countries was a total of US $ 19.1 billion that fall 
short of the real target set by the United Nations [6].  With the realization of failed targets, the UN General 
Assembly endorsed the UNAIDS` ambitious Fast-Track approach in 2016 in what would later be called the 
2016 Political Declaration on Ending AIDs. This was a united commitment by the countries worldwide that 
would ensure an end to HIV by the year 2030. This was projected as long term goal but in the meantime, 
medium term goals to end the HIV epidemic focussed the year 2020. To facilitate quick realization of 2020 
goals, a sum of US$26.2 billion was projected to address the short term target by the year 2020. This further 
implied that an annual increase of US$ 1.5 billion would be required in the period 2016 to 2020 [7].  Countries 
severely hit by the HIV epidemic were expected to scale up internal funding to this effect in addition to 
establishing efficient ways of addressing the menace. Over time there has been a notable increase in domestic 
resources mobilization. In 2015, a total of US$ 10.9 billion was mobilized domestically. The amount of 
domestic funds surpassed the resources availed by donors and this accounted for 57% of total global HIV 
resources mobilised. For the period 2006 to 2016, there was an annual average increase of 11% in the total 
domestic investments aimed at eradicating the HIV epidemic [6].  Cumulatively, US $9.3 billion was directed to 
HIV prevention initiatives. This amount was 19% of the total global funds financing HIV and the resources 
mainly centred on prevention programs that would create awareness about HIV epidemic and how to prevent 
new infections. Treatment and care of persons living with the HIV virus was US$27.3, which was 55.8% of the 
global HIV total amount [6]. 
1.5 HIV/AIDS Funding gap 
As at 2015, there was a gap of US $ 9 billion between the actual resources available for reaching the UNAIDS 
2020 Fast-Track Targets versus what was required. The annual resource needs for attaining the Fast-Track 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2019) Volume 48, No  5, pp 1-9 
 
6 
 
Target have been projected to be at least 31.1 Billion US Dollars by the year 2020. This will be followed by a 
declining resource needs trend. In 2016, US $ 19.1 billion was devoted for in-county HIV programs [6]. 
However, this amount still fall short of the necessary resources by US 7.2 billion. According to [7], the total cost 
of the UNAIDS 2016-2021 entire strategy is projected to increase to US $ 22 Billion in 2020 up from about 
US$20 Billion in 2016. In 2021, this is expected to increase further to about US $ 21Billion. As part of the 
major prevention interventions, condom distribution programs are expected to consume 8% of the allocations 
while HIV testing service is expected to account for 9%. To push the prevention agenda forward, the program 
enablers allocation is the second largest budgetary allocation with 13 % of the total funding while the treatment 
process through Antiretroviral therapy will have the highest allocation of about 47% of the total allocation. Out 
of the total resources allocation, more than 30 percent is to be directed to four countries namely Nigeria, South 
Africa, Brazil and China. This is courtesy of the order of the HIV burden. About 55% of all resources are 
required for countries considered to be in the low income cluster and middle income cluster in the African 
region. The American region takes the second largest share of 16% while the Western Pacific and the South East 
Asia Regions will be allocated 13% and 8% respectively. Only 5% of the total resource will be required in the 
European region while the East Mediterranean Region will need 4% of the resource allocation.[7] Generally, 
there has been a momentous increase in the amount of resources directed to address HIV over years. 
Approximately, US$ 562.6 billion was channelled between 2000 and 2015 towards HIV activities and programs 
that would ease the HIV burden globally and fast track the goal of ensuring HIV free world.    Even with the 
recorded significant response in the HIV epidemic fight, HIV has remained a big global public health threat. The 
rate of expansion in terms of service coverage has been inadequate and the HIV epidemic effects have been 
shadowing the full benefits of services and interventions aimed at eradicating the HIV menace.  Despite 
incredible progress in the response, HIV/AIDS remains a serious public health threats in all regions. There have 
been continued discussions on the effect of increased HIV/AIDS expenditure on the reduction of incidence rate 
amongst citizens. Countries all over the world have engaged numerous prevention strategies to address the high 
HIV Incidence rates. The prevention interventions include programmes on behavior change, encouraging use of 
condoms, HIV testing, male circumcision and blood supply safety. This study therefore sought to use Panel data 
to establish the impact of expenditure directed to HIV/AIDS care on HIV incidence rate in sub-Saharan Africa 
countries.   
2. Methodology 
2.1 Theoretical Framework 
The study was anchored on theoretical framework borrowed from The Bergson-Samuelson Social Welfare 
Model. In the Bergson-Samuelson Social Welfare Model, health care trust receives financial lump sum budget 
and then decides on the budget allocation across the care programmes. Every progamme of care has a specified 
health production function which indicates the linkage between expenditure on programme and health outcomes 
in the specified programme.  The Bergson-Samuelson Social Welfare Model indicates health outcomes to 
depend on the level of spending, clinical needs of the population that is relevant to the programme of care and 
wider environmental factors pertinent to delivering the programme of care according to the following functional 
form;  
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),,( itititit znxfh          (1) 
Where, 
ith  is health outcome in country i in the period t 
itx  is expenditure by country i in the period t 
itn is the local population clinical needs relevant to HIV/AIDS in country i in the period t 
itz  is local broader environmental factors in country i relevant in the delivery of HIV/AIDS programmes 
The model implies that health outcome improves with expenditure until an optimum is realised. The nations in 
sub-Sahara African in an attempt to deal with challenges of HIV/AIDS have continued to review expenditure 
allocations on HIV/AIDS programmes. Since the clinical needs and the environmental factors affecting the 
delivery of various programmes differ across countries in Africa, the Bergson-Samuelson Social Welfare Model 
was appropriate for analysing the relationship between HIV incidence rate and HIV/AIDS expenditure.  
2.2 Empirical Model 
The study adopted The Bergson-Samuelson Social Welfare Model with modification. The health outcome in this 
study was HIV Incidence rate. The clinical needs were; number of people tested for HIV/AIDS, population on 
antiretroviral therapy, number of prevention of mother to child transmission, literacy rate while environmental 
factor considered was doctors’ population.  t was expected that a health outcome is influenced by previous 
conditions and as such the incidence rate was expressed as a function of the lagged variables of expenditure, 
clinical and environmental factors as follows: 
),,,( 1111  ititititit DPLRPMTCTTEHfHIR )                  (2) 
itHIR  is Incidence rate in country i in the period t, 
1itTEH  is total expenditure on HIV/AIDS in country i in the period t-1,  
1itPMTCT is prevention of mother to child transmission with regard to HIV in country i in period t-1, 
1itLR  is literacy rate as percentage of population aged over 15years in country i in the period t-1, 
1itDP  is population of doctors per 100,000 people in country i in the period t-1, 
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3. Results 
The objective of this study was to establish the effect of HIV/AIDs expenditure on HIV/AIDS incidence rate in 
sub-Sahara African Countries. To achieve this objective, HIV/AIDs incidence rate was regressed on the first 
differenced variables of HIV/AIDS Expenditure, number of people put on antiretroviral therapy, preventions of 
mother to child transmissions, literacy rates and doctors population. The findings are presented in table 4.4. 
Table 1: Impact of HIV/AIDS expenditure on HIV/AIDS Incidence rate 
Dependent variable: HIV/AIDS incidence rate 
Independent Variable Coefficient z-statistic Probability 
THE -0.7195381** -2.39 0.022 
PMTCT -2.13e-08** -2.06 0.046 
LR -0.0001463 -1.25 0.217 
DP -0.0005383*** -4.32 0.0000 
C -0.0516743 7.75 0.0000 
Adjusted R-squared                                                                                                     0.5539 
Wald chi2(4)                                                                                                             32.63*** 
** 
and 
***
denote the level of significance at 5 percent and 1 percent respectively. 
The results presented in table 1 show that HIV/AIDS expenditure, prevention of mother to child transmission, 
and doctor population coefficients are statistically significant while the coefficient of literacy rate is statistically 
insignificant. This shows that in the selected African countries, HIV/AIDS expenditure, prevention of mother to 
child transmission and doctors population are important determinants of health outcomes while literacy rate is 
not. According to the results, an increase in HIV/AIDS expenditure in the sub-Saharan countries by one US 
Dollar will reduce HIV/AIDS prevalence rate by 0.7195381 percent. This study results support previous 
research findings by [8] study on HIV response in South-East Asia nations which found out that increase in 
HIV/AIDS expenditure lead to decline in global HIV/AIDS incidence.    The coefficient for prevention of 
mother to child transmission was statistically significant at 5 percent level of significance. The coefficient for 
prevention of mother to child transmission was -2.13e-08. According to these results, an increase in prevention 
of mother to child transmission by one will reduce HIV/AIDS incidence rate by 2.13e-08. percent. The results 
are in agreement with [9] who found a positive relationship between prevention of mother to child transmission 
and HIV incidence.  The coefficient for doctor population was found to be statistically significant at 1 percent 
level of significance. Doctor population has significant influence on HIV/AIDS incidence rate. The coefficient 
for doctor population was -0.0005383and this implies that an increase in doctor population by one in a 
population of 100,000 people will reduce HIV/AIDS incidence rate by 0.0005383percent. These results concur 
with [10] study that found out that doctor population help in reducing new HIV/AIDS infections. The adjusted 
R-squared was 55.39% within countries, 31.73% between countries and 26.79% in the overall. This implied that 
55.39% of variations in incidence rate in the selected sub-Saharan African countries can be explained by 
variations in HIV/AIDS expenditure, prevention of mother to child transmission, literacy rates and doctor 
population within the selected African counties.  
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4. Conclusion and policy recommendations 
The major area of the wider efforts in expanding the overall investments in health is increasing the financial 
allocations towards programs addressing HIV. Despite the over-time increase in HIV fight allocations, there is 
need to scale up funding as the existing domestic and  international funding fall short of the required in 
achieving the 2030 strategy. The anticipated new resources will not only be helpful in the scaling up services 
and interventions combat HIV but will also go a long way in filling up the funding gaps that have been arising 
due to donors shifting their priorities.  To prevent new HIV infections, countries within sub-Saharan Africa will 
have to understand HIV incidence nationally, sub-nationally, and within varying population demographics. HIV 
incidence has been and still remains the most useful and widely informative measure in appreciating the 
dynamics of HIV epidemic in terms of where is most likely to occur and in whom new infections are most 
probable to occur.  To achieve the global prevention target of zero new HIV infections, there is need to adopt a 
robust health system that will actively engage and retain the target population in the whole HIV prevention and 
care services. This includes but is not limited to accessing HIV prevention services and enrolment to early 
antiretroviral therapy if they test positively for HIV. Therefore, to reduce new HIV infections, there is need to 
allocate more resources.  
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